Concepts (266)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carotid Body | 48 | 2023 | 239 | 9.710 |
Why?
|
| Hypoxia | 50 | 2023 | 668 | 6.290 |
Why?
|
| Hydrogen Sulfide | 10 | 2023 | 52 | 2.820 |
Why?
|
| Receptors, Odorant | 4 | 2023 | 37 | 2.380 |
Why?
|
| Oxygen | 14 | 2023 | 755 | 2.160 |
Why?
|
| Cystathionine gamma-Lyase | 9 | 2021 | 35 | 1.790 |
Why?
|
| Sleep Apnea Syndromes | 6 | 2023 | 107 | 1.590 |
Why?
|
| Hypertension | 10 | 2023 | 758 | 1.540 |
Why?
|
| Carbon Monoxide | 5 | 2022 | 93 | 1.470 |
Why?
|
| Oxidative Stress | 9 | 2015 | 465 | 1.440 |
Why?
|
| Adrenal Medulla | 8 | 2019 | 48 | 1.350 |
Why?
|
| Sleep Apnea, Obstructive | 6 | 2023 | 218 | 1.320 |
Why?
|
| Rats, Sprague-Dawley | 30 | 2019 | 1230 | 1.240 |
Why?
|
| Reactive Oxygen Species | 16 | 2022 | 496 | 1.190 |
Why?
|
| Rats | 34 | 2020 | 4057 | 1.160 |
Why?
|
| Sympathetic Nervous System | 2 | 2021 | 98 | 1.100 |
Why?
|
| Gasotransmitters | 4 | 2023 | 14 | 1.040 |
Why?
|
| NADPH Oxidases | 4 | 2014 | 82 | 1.030 |
Why?
|
| Respiration | 11 | 2023 | 271 | 0.990 |
Why?
|
| Heme Oxygenase (Decyclizing) | 8 | 2021 | 44 | 0.950 |
Why?
|
| Animals | 64 | 2023 | 27828 | 0.930 |
Why?
|
| Carbonic Anhydrases | 1 | 2022 | 15 | 0.800 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 7 | 2015 | 164 | 0.770 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 5 | 2020 | 182 | 0.750 |
Why?
|
| Reflex | 8 | 2022 | 80 | 0.720 |
Why?
|
| Olfactory Receptor Neurons | 1 | 2020 | 16 | 0.680 |
Why?
|
| Respiratory Mechanics | 3 | 2013 | 103 | 0.640 |
Why?
|
| Sulfites | 1 | 2018 | 31 | 0.600 |
Why?
|
| Mice, Knockout | 12 | 2021 | 2058 | 0.600 |
Why?
|
| Apnea | 5 | 2019 | 31 | 0.600 |
Why?
|
| Catecholamines | 7 | 2021 | 92 | 0.580 |
Why?
|
| Mice | 22 | 2023 | 12013 | 0.580 |
Why?
|
| Sensory Receptor Cells | 1 | 2018 | 37 | 0.570 |
Why?
|
| Blood Pressure | 12 | 2018 | 908 | 0.550 |
Why?
|
| Sensation | 1 | 2017 | 47 | 0.530 |
Why?
|
| Chemoreceptor Cells | 9 | 2014 | 65 | 0.530 |
Why?
|
| Neuronal Plasticity | 5 | 2013 | 195 | 0.520 |
Why?
|
| Carotid Sinus | 3 | 2011 | 20 | 0.490 |
Why?
|
| Endothelin-1 | 2 | 2013 | 40 | 0.480 |
Why?
|
| Hypoxia, Brain | 3 | 2014 | 43 | 0.480 |
Why?
|
| Medulla Oblongata | 5 | 2023 | 93 | 0.480 |
Why?
|
| Splanchnic Nerves | 3 | 2014 | 8 | 0.470 |
Why?
|
| Cardiovascular Physiological Phenomena | 2 | 2006 | 36 | 0.470 |
Why?
|
| Pressoreceptors | 2 | 2011 | 12 | 0.430 |
Why?
|
| Pulmonary Edema | 1 | 2014 | 51 | 0.430 |
Why?
|
| Metalloendopeptidases | 1 | 2013 | 44 | 0.430 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2013 | 66 | 0.430 |
Why?
|
| Male | 38 | 2021 | 43367 | 0.420 |
Why?
|
| Mice, Inbred C57BL | 7 | 2022 | 3313 | 0.420 |
Why?
|
| Norepinephrine | 5 | 2021 | 172 | 0.380 |
Why?
|
| Serotonin | 3 | 2009 | 218 | 0.370 |
Why?
|
| Angiotensin II | 1 | 2011 | 93 | 0.360 |
Why?
|
| Animals, Newborn | 6 | 2019 | 523 | 0.360 |
Why?
|
| Hypoxia-Inducible Factor 1 | 5 | 2020 | 43 | 0.350 |
Why?
|
| Chronic Disease | 7 | 2021 | 964 | 0.350 |
Why?
|
| Chromaffin Cells | 2 | 2021 | 37 | 0.340 |
Why?
|
| Action Potentials | 5 | 2018 | 605 | 0.340 |
Why?
|
| Oxygen Consumption | 4 | 2017 | 244 | 0.330 |
Why?
|
| Calcium | 5 | 2018 | 1182 | 0.320 |
Why?
|
| Respiratory Physiological Phenomena | 2 | 2006 | 48 | 0.310 |
Why?
|
| Phrenic Nerve | 4 | 2018 | 43 | 0.300 |
Why?
|
| Disease Models, Animal | 6 | 2021 | 2434 | 0.300 |
Why?
|
| Neurons, Afferent | 1 | 2006 | 79 | 0.260 |
Why?
|
| Calcium Channels, T-Type | 2 | 2015 | 25 | 0.240 |
Why?
|
| RNA, Messenger | 3 | 2022 | 2034 | 0.230 |
Why?
|
| Altitude Sickness | 1 | 2004 | 12 | 0.220 |
Why?
|
| Hypercapnia | 2 | 2022 | 45 | 0.210 |
Why?
|
| Mitochondria | 3 | 2006 | 564 | 0.210 |
Why?
|
| Superoxide Dismutase | 4 | 2016 | 177 | 0.210 |
Why?
|
| Signal Transduction | 5 | 2021 | 3448 | 0.210 |
Why?
|
| Urethane | 1 | 2022 | 5 | 0.200 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 2002 | 11 | 0.200 |
Why?
|
| Mole Rats | 1 | 2022 | 6 | 0.200 |
Why?
|
| Periodicity | 1 | 2003 | 119 | 0.200 |
Why?
|
| Enzyme Activation | 4 | 2013 | 695 | 0.190 |
Why?
|
| Cell Hypoxia | 3 | 2018 | 174 | 0.190 |
Why?
|
| Carbon Dioxide | 1 | 2022 | 206 | 0.190 |
Why?
|
| Calpain | 2 | 2014 | 113 | 0.180 |
Why?
|
| Erythropoietin | 1 | 2021 | 90 | 0.180 |
Why?
|
| Gases | 2 | 2018 | 31 | 0.180 |
Why?
|
| Brain Stem | 3 | 2018 | 168 | 0.170 |
Why?
|
| Metalloporphyrins | 2 | 2013 | 26 | 0.160 |
Why?
|
| Immunohistochemistry | 3 | 2014 | 1806 | 0.160 |
Why?
|
| Cells, Cultured | 4 | 2018 | 2891 | 0.150 |
Why?
|
| Vasomotor System | 1 | 1998 | 13 | 0.150 |
Why?
|
| Receptors, GABA-A | 1 | 1998 | 33 | 0.150 |
Why?
|
| Alkynes | 1 | 2018 | 19 | 0.150 |
Why?
|
| DNA Methylation | 3 | 2018 | 672 | 0.140 |
Why?
|
| Glycine | 1 | 2018 | 97 | 0.140 |
Why?
|
| Receptors, Serotonin, 5-HT2 | 2 | 2009 | 15 | 0.140 |
Why?
|
| Rats, Inbred SHR | 1 | 2017 | 33 | 0.140 |
Why?
|
| Rats, Inbred WKY | 1 | 2017 | 32 | 0.140 |
Why?
|
| Protein Kinase C | 2 | 2009 | 267 | 0.140 |
Why?
|
| Protein Isoforms | 2 | 2015 | 281 | 0.130 |
Why?
|
| Humans | 21 | 2023 | 91261 | 0.130 |
Why?
|
| Respiration Disorders | 1 | 2016 | 41 | 0.130 |
Why?
|
| Electron Transport Complex I | 2 | 2018 | 32 | 0.130 |
Why?
|
| Epigenesis, Genetic | 3 | 2020 | 530 | 0.130 |
Why?
|
| Plethysmography, Whole Body | 3 | 2011 | 9 | 0.120 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2015 | 16 | 0.120 |
Why?
|
| Electrophysiology | 3 | 2006 | 402 | 0.120 |
Why?
|
| Afferent Pathways | 3 | 2005 | 78 | 0.120 |
Why?
|
| Time Factors | 6 | 2009 | 5394 | 0.120 |
Why?
|
| Arterial Pressure | 1 | 2015 | 38 | 0.120 |
Why?
|
| Solitary Nucleus | 1 | 2014 | 22 | 0.120 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2014 | 3 | 0.110 |
Why?
|
| Oxidation-Reduction | 2 | 2016 | 395 | 0.110 |
Why?
|
| Antioxidants | 2 | 2013 | 226 | 0.110 |
Why?
|
| Arteries | 1 | 2015 | 179 | 0.110 |
Why?
|
| Endothelin-Converting Enzymes | 1 | 2013 | 4 | 0.110 |
Why?
|
| Receptor, Endothelin A | 1 | 2013 | 21 | 0.110 |
Why?
|
| Calcium Channels | 1 | 2014 | 182 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 195 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 220 | 0.100 |
Why?
|
| Body Weight | 1 | 2014 | 457 | 0.100 |
Why?
|
| PC12 Cells | 3 | 2014 | 115 | 0.100 |
Why?
|
| Blotting, Western | 2 | 2011 | 795 | 0.100 |
Why?
|
| Species Specificity | 1 | 2014 | 690 | 0.100 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2009 | 44 | 0.100 |
Why?
|
| Phosphorylation | 3 | 2015 | 1132 | 0.100 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2011 | 21 | 0.090 |
Why?
|
| Gene Expression | 4 | 2016 | 1313 | 0.090 |
Why?
|
| Potassium Chloride | 1 | 2011 | 86 | 0.090 |
Why?
|
| Time | 1 | 2011 | 77 | 0.090 |
Why?
|
| Substance P | 1 | 2011 | 62 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2011 | 898 | 0.090 |
Why?
|
| Acetylcholine | 1 | 2011 | 177 | 0.090 |
Why?
|
| Sodium Channels | 1 | 2011 | 130 | 0.090 |
Why?
|
| Down-Regulation | 2 | 2009 | 521 | 0.090 |
Why?
|
| Particulate Matter | 1 | 2011 | 102 | 0.090 |
Why?
|
| Air Pollutants | 1 | 2011 | 96 | 0.090 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2011 | 201 | 0.090 |
Why?
|
| Adenosine Triphosphate | 1 | 2011 | 318 | 0.090 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 1591 | 0.090 |
Why?
|
| Ketanserin | 2 | 2006 | 10 | 0.080 |
Why?
|
| Protein Phosphatase 2 | 1 | 2009 | 17 | 0.080 |
Why?
|
| Homeostasis | 1 | 2012 | 429 | 0.080 |
Why?
|
| Nerve Net | 1 | 2013 | 389 | 0.080 |
Why?
|
| Hypoglossal Nerve | 2 | 2023 | 27 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 888 | 0.080 |
Why?
|
| Acclimatization | 2 | 2009 | 77 | 0.080 |
Why?
|
| Heart | 1 | 2012 | 581 | 0.080 |
Why?
|
| HEK293 Cells | 3 | 2015 | 660 | 0.080 |
Why?
|
| Protein Kinases | 1 | 2009 | 212 | 0.070 |
Why?
|
| Heart Rate | 2 | 2002 | 498 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2787 | 0.070 |
Why?
|
| Neural Pathways | 1 | 2009 | 320 | 0.070 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2007 | 17 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2009 | 727 | 0.070 |
Why?
|
| Pulmonary Ventilation | 1 | 2006 | 33 | 0.070 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2006 | 32 | 0.070 |
Why?
|
| Receptors, Serotonin | 1 | 2006 | 34 | 0.070 |
Why?
|
| Acetophenones | 1 | 2006 | 27 | 0.070 |
Why?
|
| Neural Conduction | 1 | 2006 | 71 | 0.070 |
Why?
|
| Serotonin Antagonists | 1 | 2006 | 35 | 0.070 |
Why?
|
| Receptors, Glutamate | 2 | 2005 | 24 | 0.070 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 320 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2009 | 405 | 0.060 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2005 | 80 | 0.060 |
Why?
|
| Angiotensin I | 1 | 2005 | 7 | 0.060 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2005 | 7 | 0.060 |
Why?
|
| Electric Stimulation | 2 | 2005 | 371 | 0.060 |
Why?
|
| Lung | 1 | 2012 | 1324 | 0.060 |
Why?
|
| Hypotension | 1 | 2005 | 71 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 1467 | 0.060 |
Why?
|
| Free Radical Scavengers | 1 | 2005 | 60 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2005 | 68 | 0.060 |
Why?
|
| Sodium Cyanide | 1 | 2004 | 6 | 0.060 |
Why?
|
| Electron Transport Complex III | 1 | 2003 | 13 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2005 | 465 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 652 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2005 | 258 | 0.050 |
Why?
|
| Genes, fos | 1 | 2003 | 24 | 0.050 |
Why?
|
| Kynurenic Acid | 1 | 2002 | 7 | 0.050 |
Why?
|
| Long-Term Potentiation | 1 | 2003 | 48 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2006 | 592 | 0.050 |
Why?
|
| Lidocaine | 1 | 2002 | 66 | 0.050 |
Why?
|
| Motor Neurons | 1 | 2023 | 178 | 0.050 |
Why?
|
| Recurrence | 1 | 2004 | 1172 | 0.050 |
Why?
|
| Baroreflex | 1 | 2020 | 8 | 0.040 |
Why?
|
| Female | 4 | 2021 | 47287 | 0.040 |
Why?
|
| Rats, Wistar | 2 | 2014 | 304 | 0.040 |
Why?
|
| NADH Dehydrogenase | 1 | 2018 | 22 | 0.040 |
Why?
|
| Infant, Premature, Diseases | 1 | 2019 | 77 | 0.040 |
Why?
|
| Bicuculline | 1 | 1998 | 18 | 0.040 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 1998 | 15 | 0.040 |
Why?
|
| GABA Antagonists | 1 | 1998 | 25 | 0.040 |
Why?
|
| Strychnine | 1 | 1998 | 7 | 0.040 |
Why?
|
| In Vitro Techniques | 3 | 2005 | 998 | 0.040 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 160 | 0.040 |
Why?
|
| Insulin Resistance | 1 | 2020 | 375 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 731 | 0.030 |
Why?
|
| Aconitate Hydratase | 1 | 2016 | 11 | 0.030 |
Why?
|
| Malondialdehyde | 1 | 2016 | 26 | 0.030 |
Why?
|
| Glutathione Peroxidase | 1 | 2016 | 24 | 0.030 |
Why?
|
| Peroxiredoxins | 1 | 2016 | 14 | 0.030 |
Why?
|
| Catalase | 1 | 2016 | 49 | 0.030 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2016 | 48 | 0.030 |
Why?
|
| Benzeneacetamides | 1 | 2015 | 12 | 0.030 |
Why?
|
| Dopamine | 2 | 2009 | 273 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 1248 | 0.030 |
Why?
|
| Brain | 2 | 2018 | 2334 | 0.030 |
Why?
|
| Essential Hypertension | 1 | 2015 | 10 | 0.030 |
Why?
|
| Heme | 1 | 2015 | 64 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2015 | 118 | 0.030 |
Why?
|
| Models, Cardiovascular | 1 | 2015 | 107 | 0.030 |
Why?
|
| Sulfides | 1 | 2014 | 67 | 0.030 |
Why?
|
| Autonomic Nervous System | 2 | 2009 | 66 | 0.030 |
Why?
|
| Cysteine | 1 | 2015 | 144 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 429 | 0.030 |
Why?
|
| Vasodilation | 1 | 2014 | 93 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2002 | 1671 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2014 | 293 | 0.030 |
Why?
|
| Pyridines | 1 | 2015 | 304 | 0.030 |
Why?
|
| Models, Biological | 1 | 2020 | 1772 | 0.030 |
Why?
|
| Polysomnography | 1 | 2013 | 151 | 0.030 |
Why?
|
| Arousal | 1 | 2013 | 171 | 0.030 |
Why?
|
| Baltimore | 1 | 2011 | 40 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 1207 | 0.020 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2011 | 32 | 0.020 |
Why?
|
| Bradycardia | 1 | 2011 | 41 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2011 | 68 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 231 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 309 | 0.020 |
Why?
|
| CpG Islands | 1 | 2012 | 160 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2009 | 121 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2009 | 139 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2009 | 189 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2011 | 792 | 0.020 |
Why?
|
| Epinephrine | 1 | 2006 | 88 | 0.020 |
Why?
|
| Superoxides | 1 | 2006 | 74 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 304 | 0.020 |
Why?
|
| Acetylcysteine | 1 | 2006 | 71 | 0.020 |
Why?
|
| Taurine | 1 | 2005 | 11 | 0.020 |
Why?
|
| Nicotinic Agonists | 1 | 2006 | 74 | 0.020 |
Why?
|
| Microinjections | 1 | 2005 | 71 | 0.020 |
Why?
|
| Elapid Venoms | 1 | 2005 | 5 | 0.020 |
Why?
|
| Ganglia, Autonomic | 1 | 2005 | 6 | 0.020 |
Why?
|
| Neurofilament Proteins | 1 | 2005 | 14 | 0.020 |
Why?
|
| Serotonin 5-HT2 Receptor Antagonists | 1 | 2005 | 7 | 0.020 |
Why?
|
| Electrochemistry | 1 | 2005 | 60 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2005 | 59 | 0.020 |
Why?
|
| Blood Gas Analysis | 1 | 2005 | 37 | 0.020 |
Why?
|
| Tidal Volume | 1 | 2005 | 55 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2005 | 187 | 0.010 |
Why?
|
| Protein Binding | 1 | 2009 | 1508 | 0.010 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2005 | 88 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2005 | 154 | 0.010 |
Why?
|
| Nicotine | 1 | 2006 | 202 | 0.010 |
Why?
|
| Wakefulness | 1 | 2005 | 135 | 0.010 |
Why?
|
| Acute Disease | 1 | 2006 | 857 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 309 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2005 | 397 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2005 | 436 | 0.010 |
Why?
|
| Neurons | 2 | 2005 | 1597 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 1995 | 0.010 |
Why?
|
| Aging | 1 | 2008 | 732 | 0.010 |
Why?
|
| Risk Factors | 1 | 2013 | 5619 | 0.010 |
Why?
|
| Vagus Nerve | 1 | 2002 | 49 | 0.010 |
Why?
|
| Heart Failure | 1 | 2011 | 1275 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1936 | 0.010 |
Why?
|
| Heterozygote | 1 | 2002 | 374 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2007 | 2514 | 0.010 |
Why?
|
| Genotype | 1 | 2005 | 1859 | 0.010 |
Why?
|
| Mesencephalon | 1 | 1999 | 64 | 0.010 |
Why?
|
| Adult | 1 | 2007 | 27213 | 0.000 |
Why?
|